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Objective: To analyze antigenic and genetic variations of Chlamydia trachomatis among the serovars obtained from 
Japanese infants. 
Methods: The polymerase chain reaction (PCR) was used to amplify a large part of the major outer-membrane protein 
gene, and restriction fragment length polymorphism (RFLP) was used to identify the serovars of C. trachomatis from 
nasopharyngeal and conjunctival swabs from Japanese infants and neonates. 
Results: The typing of 10 nasopharyngeal isolates gave the following results: seven E, one H, and two unclassified 
serovars. The typing of seven conjunctival isolates gave the following results: five D, one F, and one unclassified serovar. 
Reactive patterns of these unclassified strains, determined by PCR-RFLP, to monoclonal antibodies were different from 
those of 15 reference serovars. 
Conclusions: Characterization of unclassified variants will allow more detailed epidemiologic studies of perinatal C. 
trachomatis infections in  Japan. 
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INTRODUCTION 
Chlamydia trackomatis causes neonatal inclusion con- 
junctivitis and infantile pneumonia [l]. Fifteen serovars 
of C. trackomatis were originally classified by the micro- 
immunofluorescence (MIF) test [2]. Serologic typing 
distinguished epitopes which reside principally on 
the major outer-membrane protein (MOMP). The 
sequences of the MOMP gene, which includes four 
variable domains (VDs), have been determined for all 
15 serovars [ 3 ] .  Serovars D-K have generally been 
Corresponding author and reprint requests: 
Kei Numazaki, Department of Pediatrics, Sapporo Medical 
University School of Medicine, S.l W.16 Chuo-ku, Sapporo, 
060 Japan 
Tel: +81 11 61 1 21 11 Fax: +81 11 61 1 0352 
E-mail: numazaki@sapmed.ac.jp 
Accepted 9 April 1998 
considzred as being of urogenital tract origin. The sero- 
typing procedure for C. trackomatis detects epitopes 
situated in four VDs of MOMP. The polymerase chain 
reaction (PCR) was used to amplify a large part of the 
MOMP gene (omp 1 or ompA), including four VDs, and 
then cataloged restriction fragment length polymorph- 
ism (RFLP) was used to identi$ the serovars from 
genoqpes of C. truckomatis from nasopharyngeal swabs 
obtained from Japanese infants with pneumonia [4]. 
Serotyping with the use of monoclonal antibodies 
recognizing antigenic determinants located on MOMP 
is also a standard method for characterization of C. 
trackomatis clinical isolates. In this study, we detected the 
presence of unclassified serovars of C. trackomatis, both 
by PCR-RFLP and the reactive pattern by MIF using 
monoclonal antibodies, obtained from Japanese infants 
and neonates. 
MATERIALS AND METHODS 
Study populations 
Nasopharyngeal specimens were collected from I 0  
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infants with pneumonia, from 1 month to 1 year old, 
during the period May 1990 to September 1993. 
Clinical diagnosis of pneumonia was based on clinical 
findings and radiologic confirmation. C. trachomati5 
was isolated by culture, and chlamydial antigens were 
identified by enzyme immunoassay (EIA). Conjunc- 
tival swabs were also collected from seven neonates 
under 1 month old with inclusion conjunctivitis during 
the sanie period. 
PCR-RFLP analysis 
PCK amplification and RFLP analysis were used to 
detect and characterize serovars of C. trachomatic as 
described previously [5,0]. From nasopharyngeal speci- 
mens, IINA was extracted in lysis buffer (10 mM 
Tris-HC1, Tween-20 0.5‘%, 1 nlM EDTA) containing 
proteinase K 0.1 mg/niL, and this was followed by 
phenol/chloroform extraction. The primers used in 
the PCK study were based on conserved regions of 
the DNA sequence omp2  (or o m p A )  of MOMP of 
C. tracliomatir. The following oligonucleotides were 
designed for PCR as primers 17): T-l(5’-AGAGGGA- 
GTATGAAAAAACTCTTGAAATATCG-3’), and T-2 
(-5’TTAGAATCTGAATTGAGCATTTACGTGAGC 
-3’). Synthetic oligonucleotides used as primers were 
prepared with a DNA synthesizer Model 7500 
(Milligan Chrp., Kedford, MA, USA) and purified by 
high-pressure liquid chromatography. The isolated 
DNA, primers and reagents were heated a t  94°C for 
5 min before the addition of 2 U Eq polymerase 
(Perkin-Elmer Cetus, Norwalk, CT, USA), to give a 
final volume of 100 pL. The protocol of cyclec was as 
follows: cycles 1-40 were performed by a DNA 
Thermal Cycler (Perkin-Elmer Cetus), at 94OC for 
1 min (denaturation), 50°C for 2 inin (annealing), 
and 72OC for 3 Inin (extension). The PCR reaction 
mixture was analyzed by electrophoresis on agarose gel 
(Seakeni agarose 1.2%, 40 mM Tris-acetate, 1 niM 
EDTA) containing ethidiuni bromide. Amplified DNA 
was visualized by ultraviolet fluorescence and recorded 
by Polaroid photography. Genotyping was performed 
by HinfI ,  Hind111 and HhnI restriction analysis of 
amplified omp 1 according to a previously described 
procedure [4,7]. Validation of the choice of restriction 
enzymes has also been described 171. Aliquots of 
amplified DNA were digested with restriction enzymes 
and extracted once with phenoVchloroform. The 
PCR fragments were also digested by each of the three 
enzymes xparately. The resulting fragments were 
examined by agarose gel electrophoresis. Each amp 7 
genotype was defined by testing a reference strain 
representing each of the 15 serovars (obtained from the 
Washington Kesearch Foundation, Seattle, USA). 
Comparison of the KFLP profiles of each clinical 
isolate with those of the reference strains was per- 
formed to assign a serovar from the genotype of each 
clinical isolate. 
isolation and antigen detection of C. rrachomaris 
IIEAI-dextran- and cycloheximide-treated HeLa 229 
cells were used to isolate C. tracliomatis from the har- 
vested culture media as reported previously [8] .  A com- 
mercially available EIA kit (IDEIA CHLAMYDIA, 
Dako Diagnostics Co., USA) was also used to detect 
genus-specific chlamydia1 antigens in lipopolysac- 
charide (LPS) epitope of the cell wall 191. Testing and 
interpretation of the results were performed according 
to the manufacturer‘s instructions. 
Antigenic analysis with monoclonal antibodies 
Clinical isolates of C. rrar\mrnarir were inoculated onto 
monolayers of HeLa 229 cells and prepared as described 
previously [ 101. All clinical isolates were also positive 
by EIA. Prepared antigen5 of clinical isolates were 
reacted with monoclonal antibodies by the indirect 
MIF test. The highest dilution of each monoclonal 
antibody which showed definite fluorescence was con- 
sidered as the endpoint. We used several different mono- 
clonal antibodies reactive to C. trachomati5 L2/434/Bu 
strain [10,111. 
RESULTS 
Applied to 15 reference strains, this PCK-RFLP pro- 
cedure allowed us to determine 13 of the 15 serovars 
of C. tuac-hornatis. The S and Ba serovars, however, 
could not be separated by this method (results not 
shown). The possibility that clinical isolates frequently 
have variant patterns was explored by analyzing 17 
clinical isolates which were found by culture and 
antigen detection to contain Chlamydia species. Eight 
of ten isolates of nasopharyngeal origin and six of 
seven isolates of conjunctival origin could be un- 
equivocally assigned to one of the 15 reference serovars 
with a restriction endonuclease profile identical to that 
of the prototype (Figure 1) .  The typing of 10 naso- 
pharyngeal isolates gave the following results: seven E, 
one H, and two unclassified serovars by PCK-RFLP. 
The typing of seven conjunctival isolates gave the 
following results: five 11, one F, and one unclassified 
serovar. 
We characterized these unclassified strains by MIF 
using monoclonal antibodies reactive to C. tunrhomatis 
L2/434/Bu strain (Table 1). Reactive patterns of these 
unclassified strains were also different from those of 15 
reference serovars. The reactive patterns of the two 
unclassified nasopharyngeal isolates were similar to 
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Figure 1 Digestion patterns of the PCR-amplified ompl gene of the MOMP from C. tvachomatis serovars. (A) HinfI, 
Hind111 and HhaI cleavage patterns of ompl from reference E serovar,E/UW-S/CX strain (lanes 2-4), and a nasopharyngeal 
clinical isolate (lanes 5-7). (B) HinfI, Hind11 and HhaI cleavage patterns of ompl from reference H serovar, H/UW-4/CX 
strain (lanes 2-4) and from a nasopharyngeal clinical isolate (lanes 5-7). Lane 1: molecular weight markers. Fragment sizes (in 
bp) of a molecular weight ladder are shown on the left. 
Table 1 Reaction of monoclonal antibodies to clinical isolates from conjunctival swabs and reference serovars 
Monoclonal antibodies 
2F3 4D8 lFlO 4G8 4 c 5  3C5 5F9 3G5 3D3 3C3 Identified 
serovars 
Reference 
srrovars 
+ - - D ++ + + +/- - - - 
F ++ ++ + ++ + /- + + - - - 
Clinical 
isolates 
1 +/- +/- D + + - 
2 - Unclassified + 
+ + + - D 3 + + /- - 
4 +/- + D + + - 
5 +/- +/- + D + 
6 + +/- +/- D 
7 + t /- + +/- + + /- +/- F 
- - - - - 
- - - - - - - - 
- - - 
- - - - - 
- - - - - - 
- - - - - - - 
- - - 
MIF titers: -, <1:100; +/-, 1: lOO;  +, 1 : l O O  to <1:1000; ++, 21:lOOO. 
those of the unclassified conjunctival isolate. All three 
unclassified isolates reacted with monoclonal antibody 
2F3. 
DISCUSSION 
Chlamydia1 infections in infants are usually caused 
by mother-to-infant transvaginal transmission of C. 
trachomatis. Antigen detection of C. trachomatir from the 
endocervix has been utilized widely for the purpose of 
the screening of chlamydial infections during preg- 
nancy. These tests are easily performed and less costly 
than culture, but they have lower sensitivity and low 
positive predictive values in low-prevalence populations 
such as that of Japan. Pneumonia due to C. trachomatis 
is a disease limited mainly to infants under 6 months of 
age [ 1,121. We reported four infants who developed 
neonatal C. tvachomatir infections and whose mothers 
had negative chlamydial EIAs during pregnancy [13]. 
Although transmission of the organism from mothers 
to their infants generally occurs at the time of delivery, 
with passage of the infant through the infected cervix, 
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the possibility of intrauterine infection has been 
reported [ 1 1. Seropositivity for C. tvuchoriiutis is also 
associated with perinatal complications [14,15]. Early 
diagnosis and appropriate treatment of chlamydial 
infections may reduce these complications. 
We have used the PCR assay to amplify onzpl, a 
large part of the MOMP gene. The sequences of 
MOMP gene for all 15 serovars allowed the construc- 
tion of restriction endonuclease cleavage-site maps 
that confirm the fragment-size patterns observed by 
electrophoresis [ 3 ] .  Sequencing the entire MOMP 
gene and cataloging the sequences of VDs of all serovars 
has confirmed the molecular basis of the serotyping 
procedure and provided a method for determining 
serovars by PCR-RFLP [16]. Not only 15 classical 
serovars but also at least four serovariants (Da, Ia, Laa 
and Ga) have been described. Genovariants have also 
been reported for most serovars [I 71. However, not all 
reference serovars of serovariants were available for 
analysis. The RFLP method for typing allows quick 
and objective identification of serovars of C. truclzoriiufis. 
Theoretically, application of a siniilar approach to C. 
prrcirmoriine or C. psirmci serovars should prove fruitful. 
For that purpose, the choice of a gene with demon- 
strated heterogeneity, such as MOMP of C. truclzorriatis, 
15 necessary. 
C. trnrhor?intir serovars of A, B, Ba and C have been 
predoniinantly associated with endemic trachoma [ 171. 
In contrast to urogenital chlamydial infection, trachoma 
is J household disease that has disappeared in many parts 
of the world because of improved living conditions and 
hygiene. Although Japan used to be an endemic area 
fbr trachoma, the serovars that we identified in this 
study, i.e. D, E, F and H, were similar to those reported 
in other studies from lion-trachoma-endemic areas 
1181. These identified serovars were thought to be 
of urogenital tract origin. However, there is no clear 
distinction between the serovars of endemic trachoma 
and those associated with sexually transmitted diseases 
(STD). 
We were able to distinguish all classical serovars of 
urogenital tract origin by the present method of PCK- 
KFLP. Although we have already used additional endo- 
nucleases and monoclonal antibodies (data not shown), 
it was not possible to classify these untypeable clinical 
isolates. It  was also not possible to choose one of the 
most closely related profiles of prototype strains with 
the KFLP assay. However, the reactive pattern of the 
unclassified strains with monoclonal antibodies was 
most closely related to that of reference serovar I). 
Unclassified serovars may be new strains or serovariants. 
There was not enough evidence to be sure that these 
unclassified clinical isolates were indistinguishable and 
represented a clone. DNA sequencing or other mol- 
ecular biological assays seemed to be necessary to analyze 
unclassified strains. The etiologic roles in pathogenesis 
of these unclassified serovars are still unknown. 
Antigenic variations of C. truchoriiutis were also 
considered among the strains of nasopharyngeal and 
conjunctival origin in our study. Only a limited 
number of variants have been distinguished by serologic 
methods [19]. A larger study involving many more 
clinical isolates and a battery of restriction enzymes ma)- 
be necessary to catalog unclassified serovars. Character- 
ization of unclassified variants will allow more detailed 
epidemiologic studies of perinatal C. truchoniutis infec- 
tions in Japan. 
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